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DObjectives: To summarize the clinical outcomes of totally thoracoscopic closure of a ventricular septal defect
(VSD).
Methods: Totally thoracoscopic VSD closure was performed in 119 patients (66 boys; mean age, 7.1  3.6
years). An additional 35 patients undergoing open-chest VSD closure were selected as a control group. Using 3
port incisions in the right chest, pericardiotomy, bicaval occlusion, atriotomy, and VSD closure were performed
by thoracoscopy without the aid of a robotically assisted surgical system.
Results: Cardiopulmonary bypass and aortic crossclamp times were 42.2  9.8 and 32.5  7.3 minutes,
respectively. There were no deaths but 1 patient required insertion of a permanent pacemaker as a result of
postoperative atrioventricular conduction block. The length of stay in the intensive care unit (11.0  2.6 vs
22.9  4.9 hours, P< .01) or postoperative hospital stay (4.2  1.1 vs 6.6  2.1 days, P< .03) in the
thoracoscopic group were shorter than in the control group. The percentage of patients who required
postoperative opioid analgesics in the thoracoscopic group was lower than in the control group (31.9% vs
74.2%, P< .001). Rate of blood transfusion during the operation (17.6% vs 65.7%, P ¼ .001) and the
postoperative use of opioid analgesics (31.9% vs 74.3%, P ¼ .003) in the thoracoscopic group was lower
than in the control group. Transesophageal echocardiographic analysis 4.6  2.3 months after the operation
showed complete closure of the defect.
Conclusions: Totally thoracoscopic closure of VSD through a 3-port entry was safe and effective. (J Thorac Car-
diovasc Surg 2014;147:863-8)Ventricular septal defect (VSD) is one of the most common
congenital cardiac defects found in children. Minimally
invasive surgical approaches have been applied to repair
VSDs to minimize surgical trauma and improve the
cosmetic results.1,2 Totally endoscopic closure of
congenital heart defects is an emerging technique
whereby the defects are closed entirely by thoracoscopy
via small port accesses in the right chest wall. It
has been mainly used in the closure of atrial septal
defects.3-10 Compared with conventional sternotomy,
totally thoracoscopic atrial septal defect closure was
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The Journal of Thoracic and Cabetter quality of life.6,7 Most previously reported
thoracoscopic closures of congenital heart disease
required the assistance of robotic techniques.3-11 In recent
years, we have developed a totally endoscopic technique
for the closure of atrial septal defects or VSDs in adults
and small children, without the need for robotic
assistance.12,13 The aim of the present study was to
summarize the technical details of the procedure and the
clinical outcomes of the patients who underwent totally
thoracoscopic repair of a VSD through a 3-port entry
without the aid of a robotically assisted surgical system.
PATIENTS AND METHODS
Patient Selection
This study was approved by the institutional review board of Qilu
Hospital and Liaocheng People’s Hospital. Written informed consent
was obtained from all participants before the study. Between June 2009
and March 2013, patients with congenital VSD were selected from the
Departments of Cardiac Surgery in the 2 hospitals. The selection criteria
were (1) VSD of any size; (2) more than 2 years old with a body weight
of more than 15 kg; (3) pulmonary arterial systolic pressure (measured
by echocardiography) less than 90 mm Hg; (4) no previous history of
lung disease or surgeries on the right chest; and (5) no other cardiovascular
disease or chronic illnesses.
Anesthesia
After induction of general anesthesia, a left-sided double-lumen
endotracheal tube (50 kg) or single-lumen endotracheal tube (<50 kg)
was placed to allow for single-lung ventilation. The respiration rate wasrdiovascular Surgery c Volume 147, Number 3 863
Abbreviations and Acronyms
ICU ¼ intensive care unit
VSD ¼ ventricular septal defect
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Dset between 18 and 30/min and the arterial oxygen saturation rate was
maintained at more than 97%. After the induction of general anesthesia,
a transesophageal echocardiography probe was inserted to monitor the
VSD closure. Cardiopulmonary bypass was established peripherally
through the femoral vein and femoral arteries.14 A 24F/29F Carpentier
double-lumen catheter (Medtronic Inc, Minneapolis, Minn) or a 14F/22F
double-lumen catheter (Kangxin, MN, Changzhou, China) was inserted
through the right femoral vein into the inferior and superior vena cava. A
second catheter (7F to 21F, Medtronic or Kangxin) was inserted into the
right femoral artery and was retrogradely advanced to the abdominal aorta
for perfusion.Surgical Techniques
The patient was positioned in a 15 to 20 left lateral decubitus position.
Three small incisions (ports) were made on the right side of the chest
(Figure 1). Port 1 (1-1.5 cm)was located in the third intercostal space inside
the right midclavicular line (Figure 1). This port was for the insertion of
surgical instruments such as tissue forceps using the left hand (for a
right-handed operator). Port 2 (1-1.5 cm) was for the entry of instruments,
such as scissors, suture needle, handled by the right hand of the operator. It
was located in the fifth or sixth intercostal space outside the right
midclavicular line (Figure 1). Port 3 (1.5-2.0 cm) was located in the fourth
intercostal space between the midaxilliary line and anterior axillary line
(Figure 1). This port was for the placement of the thoracoscope.
Once the ports were made, a tissue retractor (Hangtian Kadi, Beijing,
China) was inserted into each of the 3 ports to keep the ports open and
to facilitate the insertion or withdrawal of the instruments or thoracoscope
(Figure 2). First, a thoracoscope (Olympus Corporation, Tokyo, Japan)
was inserted through port 3 to visualize the right mediastinum. Under the
vision of the thoracoscope, other surgical instruments were inserted
through port 1 and port 2 to avoid injuries to the right internal thoracic
artery and other vessels inside the right chest during the procedures.
Other surgical instruments such as forceps or scissors were conventional
instruments for thoracoscopic surgery (Scanlan International, St Paul,
Minn).
Pericardiotomy was performed and 1 suture was inserted to suspend the
pericardium. Caval snares were placed in the superior and inferior vena
cava before commencing cardiopulmonary bypass. A 3-mm incision was
made between the left superior pulmonary vein and the left atrium for
the insertion of a left atrium drainage tube. The thoracoscope was then
removed from port 1 and repositioned through port 2 to visualize the
root of the aorta. An aortic crossclamp was positioned on the ascending
aorta, and a perfusion needle was inserted through port 3 to the aortic
root for the delivery of cold St Thomas’ Hospital cardioplegic solution to
achieve cardiac arrest. The thoracoscopy was then repositioned through
port 3 to visualize the right atrium. Tissue forceps and scissors were in-
serted through port 1 and port 2, respectively. After the right atrium was
opened from a site parallel to the atrioventricular annulus, 3 stay sutures
were placed on the incision to expose the intraatrial structure. The tricuspid
valve leaflets were pulled apart and 1 stay suture was placed on the inter-
ventricular septum to expose the VSD. For a defect less than 6 mm, direct
suture (5-0 or 4-0 Prolene) was used for closure. A bovine patch (Bairen
Med Pharma Co, Beijing, China) was used to repair defects of 6 mm or
more (Figure 3), using running Prolene sutures (Ethicon, Somerville,
NJ). The DeVega technique or an artificial tricuspid valve ring (Bairen
Med Pharma Co, Beijing, China) was used to repair tricuspid valve
regurgitation.864 The Journal of Thoracic and Cardiovascular SurgAfter VSD closure, the right atrium was closed and the air was
exhausted from the left heart. The aortic crossclamp was released and
the patient was rewarmed. The integrity of the VSD closure was confirmed
by transesophageal echocardiography and protamine sulfate (1:1) was
administered to reverse the actions of heparin. After adequate hemostasis
was achieved, all instruments were removed from the chest, and an
18-24F chest tube was inserted in the right pleural space through port 2
for drainage. The cannulas in the right femoral vein and artery were
removed and incisions on the blood vessels were closed with sutures.
To compare operational data and the requirement for postoperative an-
algesics between conventional and thoracoscopic VSD closure, 35 patients
undergoing open-chest surgery for VSD closure between June 2009 and
March 2012 were selected. These patients were matched according to the
type of VSD with the last 35 patients in the thoracoscopic group.
Perioperative Management
Before the surgery, education and counseling were provided to all
participants on surgical techniques, possible clinical outcomes, potential
complications, and postoperative self-care measures. Lung function tests
were routinely performed in all patients before the surgery. The lungs
were inflated every 20 minutes during the operation. The femoral artery
and vein were assessed by color Doppler ultrasonography. Bedside chest
radiographs were routinely obtained in the intensive care unit (ICU) to
exclude complications in the lungs. Mechanical ventilation was ceased
once the patient’s hemodynamics stabilized in the operating room or in
the ICU.
Statistical Analysis
SPSS v13.0 (SPSS, Inc, Chicago, Ill) was used for the statistical anal-
ysis. Quantitative variables are expressed as themean standard deviation.
Differences between multiple groups were compared by one-way analysis
of variance. Categorical variables were compared by the c2 test.RESULTS
A total of 276 patients were screened initially and 119
were recruited to this study. The main reasons for exclusion
were (1) less than 2 years old or body weight less than 15 kg
(n¼ 122); (2) older than 2 years but, as seen on the Doppler
ultrasonography examination, the femoral artery or vein
was too small (<1.3 mm in diameter) for canalization
(n ¼ 11); (3) pulmonary artery systolic pressure 90 mm
Hg or higher (n ¼ 17); and (4) a history of lung disease or
right chest surgery preventing insertion of the thoracoscope
(n ¼ 5).
Of the 119 patients selected, 66 were boys and 53 were
girls; the mean age was 7.1  3.6 years (range, 2-36 years).
The mean body weight was 32.4 7.8 kg (range, 18-68 kg).
Echocardiographic examination showed type I (membra-
nous) VSD in 64, type II (paramembranous) VSD in 51,
type III (arteriovenous canal type or inlet septum type) in
3, and type IV in 1. The size of the defect ranged from 4
mm to 14 mm. Twenty-eight patients had mild pulmonary
hypertension (pulmonary arterial pressure, 30-40 mm
Hg), 22 patients had moderate pulmonary hypertension
(pulmonary arterial pressure, 40-59 mm Hg), and 6
had severe pulmonary hypertension (pulmonary arterial
pressure, 60-90 mm Hg). Sixteen patients also had tricuspid
regurgitation as a result of right ventricular dilatation.ery c March 2014
FIGURE 1. Location of the 3 ports on the right chest wall.
FIGURE 3. Closure of a ventricular septal defect (VSD).
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DValvuloplasty using the DeVega technique and Edward ring
was performed in 9 and 3 patients, respectively, after the
VSD repair in the same procedure. Follow-up echocardio-
graphic studies showed no tricuspid regurgitation in these
patients.
One patient had bleeding as a result of injury to the infe-
rior vena cava and the right atrium. Another patient had
bleeding from the ascending aortic where a needle was in-
serted to perfuse cardioplegic solution. In both cases, theFIGURE 2. Function of the 3 ports.
The Journal of Thoracic and Cachest incision at port 2 was extended to 4-5 cm for better
visualization of the bleeding sites, which were successfully
stopped with sutures. Thoracoscopic VSD repair was
completed successfully after the bleeding from the inferior
vena cava or ascending aorta was stopped.
All patients survived the operation and were discharged
from the hospital in 4 to 6 days. No patient in this cohort un-
derwent reoperation for bleeding after the VSD repair. The
mean cardiopulmonary bypass time was 42.2 9.8 minutes
(range, 34-142 minutes). The mean aortic crossclamp time
was 32.5  7.3 minutes (range, 25-57 minutes). Once the
aortic clamp was removed, the heart beat resumed sponta-
neously in 84 patients. In 33 patients, a 50-W direct current
shock through the chest wall was administered to cardiovert
the fibrillating heart back to sinus rhythm. The mean me-
chanical ventilation time was 2.1  1.2 hours (range, 1-19
hours) and the mean time in the ICU was 11.2  3.6 hours
(range, 4-28 hours). There was no statistically significant
difference in the mean mechanical ventilation time (2.2 
1.3 vs 2.0  1.1 hours, P> .05) and time in the ICU
(11.4  3.9 vs 11.0  3.2 hours, P> .05) between the 6
patients with severe preoperative pulmonary hypertension
and those with mild or moderate preoperative pulmonary
hypertension.
In all patients, transesophageal echocardiography imme-
diately after the VSD repair showed complete closure with
no residual shunt. Three patients (2.26%) experienced
arrhythmia, 1 had high-degree atrioventricular conduction
block, which recovered spontaneously within 24 hours of
the operation. One patient had third-degree atrioventricular
conduction block that had not recovered spontaneously
within 7 days of the operation and was fitted with a perma-
nence pacemaker. The other patient had atrial fibrillation af-
ter the VSD repair but sinus rhythm returned after 52 hours.
One (0.75%) had residual shunting measuring 1 mm, which
closed itself 1 month after the operation. One patientrdiovascular Surgery c Volume 147, Number 3 865
TABLE 1. Comparison of operational data between the thoracoscopic
closure group (study) and the control group
Study
(n ¼ 119)
Control
(n ¼ 35) P
Age (y) 7.1  3.6 7.8  4.3 .106
Male, n (%) 66 (55.4) 18 (51.4) .623
Body weight (kg) 32.4  7.8 34.5  9.2 .189
Perimembranous VSD, n (%) 55 (46.2) 16 (45.7) .789
Membranous VSD, n (%) 64 (53.8) 19 (55.3) .671
Total operation time (min) 86  15 124  18 .002
Cardiopulmonary bypass (min) 42.2  9.8 48  4 .077
Aortic crossclamp time (min) 32.5  7.3 29.9  3.4 .059
Mechanical ventilation time (h) 0.3  0.4 4.9  3.2 .006
Intensive care stay (h) 11.0  2.6 22.9  4.7 .009
Postoperative hospital stay (d) 4.2  1.1 6.6  2.1 .036
Volume of chest drainage (mL) 55  12 237  66 .001
Rate of blood transfusion, n (%) 21 (17.6) 23 (65.7) .001
Postoperative analgesics, n (%) 38 (31.9) 26 (74.3) .003
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in 2 days after chest physiology therapy.
Twenty-one patients (16%) required a blood transfusion
of 400 mL each during the procedure. The total volume of
the postoperative chest drain ranged from 30 to 460 mL
(mean, 55  12 mL). Patients have been followed up for
5.2  3.9 months (3-12 months) with no signs of residual
shunt on transthoracic echocardiography. Patients resumed
work or schooling between 14 and 23 days (median, 16
days) after the surgery.
As shown in Table 1, there was no significant difference
in age, sex, cardiopulmonary bypass time, and aortic cross-
clamp time between the thoracoscopic and control groups
(P > .05). In the thoracoscopic group, total operation
time, mechanical ventilation time, and blood loss during
surgery were significantly less than in the control group
(P < .01), and the ICU or hospital stays were shorter
(P<.05). In the thoracoscopic group, 38 (31.9%) patients
required opioid analgesics. In the control group, 26 patients
(74.2%, P<.01) were administered with opioid analgesics
for 1 to 2 days after the surgery.
Comment
We have previously reported our initial experience on
totally thoracoscopic repair of VSD in 36 patients from a
single hospital.12 The present study is an extension of our
previous report and summarizes the results of 119 patients
treated by the same operator (Ma ZS) at 2 tertiary hospitals.
Compared with patients treated through conventional ster-
notomy, the totally thoracoscopic approach was associated
with a shorter operation time, shorter postoperative hospital
stay and shorter time in the ICU, lower rate of blood trans-
fusion, and lower rate of postoperative analgesics. A perma-
nent complication was observed in 1 patient who had
complete atrioventricular conduction block that required
insertion of a permanent pacemaker. There were no other866 The Journal of Thoracic and Cardiovascular Surglong-term complications during a mean follow-up of 5.2
months.
In our first report, we excluded patients with supracristal
or muscular VSD because of the difficulties in visualizing
and accessing these types of defects.12 In the last 2 years,
we have extended totally thoracoscopic closure to almost
all types of VSDs. Suprcristal or subarterial VSDs with a
diameter less than 4 mm can be closed by direct suturing
without the need for a patch. Theoretically, muscular
VSDs (type IV) close to the apex or distant to the tricuspid
annulus are difficult to access through the chest ports. Fortu-
nately, this type of VSD is rare and, in the present cohort, we
encountered only 1 patient with muscular VSD, which was
successfully closed with the totally thoracoscopic approach.
Totally thoracoscopic closure of VSD as well as other
types of congenital heart defects can be limited by the pa-
tient’s age or body weight. Younger children or children
with a low body weight tend to have smaller femoral veins
and arteries, which may hinder the insertion of catheters for
peripheral cardiopulmonary bypass. Also, these patients
often have a thoracic cavity that is too small to allow
optimal manipulation of the thoracoscope and other surgi-
cal devices within the chest. In the present study, 276 pa-
tients were initially screened for total thoracoscopic
closure but almost half of these patients were excluded
mostly because they were less than 2 years old or their
body weight was less than 15 kg. Some patients were older
than 2 years but preoperational Doppler ultrasonography
examination showed a small femoral artery or vein that
was not suitable for catheterization. In younger children
with a small femoral vein (<1.3 mm in diameter), peripheral
cardiopulmonary bypass can be established through cathe-
terization of the internal carotid vein to enable totally thor-
acoscopic closure of VSD.13 Overall, there is limited
experience in totally thoracoscopic VSD repair in younger
children with small femoral blood vessels and a small chest
cavity, and conventional closure via sternotomy is probably
a safer option.
In the present study, we also included 6 patients with a
preoperational pulmonary systolic pressure between 60
and 90 mm Hg; in the past, these patients were excluded.12
There were no perioperative mortalities or short-term
complications in these patients with severe preoperational
pulmonary hypertension. There was no statistically signifi-
cant difference in the mean mechanical ventilation time and
duration of stay in the ICU between the 6 patients with
severe preoperative pulmonary hypertension and those
with mild or moderate preoperative pulmonary hyperten-
sion. However, the short- and long-term safety of patients
with severe preoperational pulmonary hypertension after
totally thoracoscopic VSD repair needs further investiga-
tion through larger and multicentered trials.
In this study, we were unable to conduct a randomized
trial to compare the safety and efficacy of totally endoscopicery c March 2014
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Dand conventional surgery for VSD repair. In addition, the in-
vestigators were blinded to the postoperative care of the pa-
tients. Therefore, interpretation of the postoperative
mechanical ventilation time, ICU and hospital stay, and
the use of postoperative analgesics between the 2 groups re-
quires some caution. In our center, postoperative extubation
is usually performed in the ICU because many patients
(47% in the present study) have pulmonary hypertension
when presented to us for corrective surgery as a result of
late diagnosis. With the endoscopic approach for VSD
closure, we have become more confident about extubating
in the operating rooms, hence the reduced mechanical
ventilation time and shorter ICU and hospital stays. Sixty-
six percent of control patients required blood transfusion
as a result of blood loss from the mediastinum and the ster-
notomy wound during the operation, whereas the transfu-
sion rate in the study group was only 18%.
In the past, robotics techniques have been used for totally
endoscopic repair of congenital heart defects, mostly atrial
septal defects.3-6 In the present study, robotics was not used,
and the addition of these robotics techniques probably
would not further enhance our techniques in VSD repair.
With the current endoscopic approach, we were able to
display the intrathoracic operation field on a large
television screen and the operators were able to visualize
the thoracic and cardiac anatomy and the intrathoracic
surgical instruments very much in the same fashion as in
an open-chest surgery. The technique is also relatively sim-
ple to learn.8,12
In conclusion, totally thoracoscopic repair of VSDs
through a 3-port entry without the aid of a robotically assis-
ted surgical system seems to be safe and effective. However,
this technique is only suitable for children who are 2 years
or older with a body weight of more than 15 kg.References
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DrWilliamM. DeCampli (Orlando, Fla). In this series of 119
patients undergoing endoscopic VSD repair Professor Ma and col-
leagues have demonstrated the safety and efficacy of the procedure
and the superiority of a number of outcome measures compared
with the conventional open technique. This group’s results build
on their 3 previously published series of endoscopic ASD and
VSD repairs in our journals.
For thosewho have not embraced lesser invasive surgery, it is no
longer just video gaming. Prospective randomized studies now
demonstrate its superiority in a broad variety of operations in mul-
tiple surgical specialties. Although there is no class 1 evidence for
better outcomes in pediatric cardiac surgery, case-control studies
such as this one support that view. In operations with essentially
zero mortality, outcome measures such as length of stay and
time to return to school or to work are important and do seem to
be better with a lesser invasive approach.
I have 3 questions and I’ll give them to you one at a time.
First, you report significantly less bleeding and transfusion
requirement, 16% versus 67%, with the endoscopic versus conven-
tional approach. That’s a large difference. To what do you ascribe
this difference? The cardiopulmonary bypass times are
comparable. Is all the blood loss from the skin and the sternal
incision?
Dr Ma. Yes, I think that we may ascribe the blood loss to the
incision and partly the sternotomy. The average body weight of
children is much smaller than the adult population. The blood
loss during this period was comparatively larger than in adults.
Dr DeCampli.My second question is as follows. Many groups,
including one of our moderators, have published favorable results
of a sternum-sparing subxiphoid approach for repair not only of
VSD but also tetralogy of Fallot, arteriovenous canal and even
mitral valve repair in children. This approach avoids size-limiting
femoral cannulation and is more versatile. What are your thoughts
on comparing this approach with your totally endoscopic
approach?
DrMa. I don’t have experience in that procedure, but it has lim-
itations in many operations. I think our procedures leads to less
trauma, and has better cosmetic results.
Dr DeCampli. Lastly, why cannot you repair muscular VSDs
with your approach? How about inlet VSDs? Granted that robotsrdiovascular Surgery c Volume 147, Number 3 867
Congenital Heart Disease Ma et al
C
H
Dare expensive, but do you think a robotic approach could nonethe-
less potentially increase your versatility?
DrMa. I think that muscular VSDs are usually situated near the
apex and usually have many outlets on the right ventricular side.
So I have never tried to do this.868 The Journal of Thoracic and Cardiovascular SurgThe second, I have done many inlet VSD repairs. I think that an
inlet VSD is one of the best indications for totally thorascopic pro-
cedures, whether the repair is done by direct sutures or patches.
Thirdly, I don’t have experience in robotic procedures because
my hospital does not have this equipment.ery c March 2014
